Advanced Glycation End Products, Diabetes, and Bone Strength

Teriparatide in patients with osteoporosis and type 2 diabetes

(2016) Ann V. Schwartz et al.   BONE

Bone Formation is Affected by Matrix Advanced Glycation End Products (AGEs) In Vivo

(2016) Xiao Yang et al.   CALCIFIED TISSUE INTERNATIONAL

Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes

(2016) Jessica R. Furst et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Autophagy protects osteoblasts from advanced glycation end products-induced apoptosis through intracellular reactive oxygen species

(2016) Lei Yang et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Advanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic Mice

(2016) Mishaela R. Rubin et al.   PLoS One

Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells

(2015) Ken-ichiro Tanaka et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Nonenzymatic Glycation and Degree of Mineralization Are Higher in Bone From Fractured Patients With Type 1 Diabetes Mellitus

(2015) Delphine Farlay et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Influence of cross-link structure, density and mechanical properties in the mesoscale deformation mechanisms of collagen fibrils

(2015) Baptiste Depalle et al.   Journal of the Mechanical Behavior of Biomedical Materials

Advanced Glycation End Product 3 (AGE3) Suppresses the Mineralization of Mouse Stromal ST2 Cells and Human Mesenchymal Stem Cells by Increasing TGF-β Expression and Secretion

(2014) Masakazu Notsu et al.   ENDOCRINOLOGY

High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control

(2014) T. Neumann et al.   OSTEOPOROSIS INTERNATIONAL

Circulating Levels of Carboxy-Methyl-Lysine (CML) Are Associated With Hip Fracture Risk: The Cardiovascular Health Study

(2013) Joshua I Barzilay et al.   JOURNAL OF BONE AND MINERAL RESEARCH

TBS (Trabecular Bone Score) and Diabetes-Related Fracture Risk

(2013) William D. Leslie et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Advanced Glycation End Products (AGEs), but not High Glucose, Inhibit the Osteoblastic Differentiation of Mouse Stromal ST2 Cells Through the Suppression of Osterix Expression, and Inhibit Cell Growth and Increasing Cell Apoptosis

(2012) Kyoko Okazaki et al.   CALCIFIED TISSUE INTERNATIONAL

Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures

(2012) Janina M Patsch et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Decreased PTH Levels Accompanied by Low Bone Formation Are Associated with Vertebral Fractures in Postmenopausal Women with Type 2 Diabetes

(2012) Masahiro Yamamoto et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Heterogeneous Glycation of Cancellous Bone and Its Association with Bone Quality and Fragility

(2012) Lamya Karim et al.   PLoS One

In situ accumulation of advanced glycation endproducts (AGEs) in bone matrix and its correlation with osteoclastic bone resorption

(2011) X. Neil Dong et al.   BONE

Association of BMD and FRAX Score With Risk of Fracture in Older Adults With Type 2 Diabetes

(2011) Ann V. Schwartz   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Bone quality and osteoporosis therapy

(2010) Regina Matsunaga Martin et al.   Arquivos Brasileiros de Endocrinologia e Metabologia

Bone mineral density in women with type II diabetes mellitus

(2010) Ruth S. Weinstock et al.   JOURNAL OF BONE AND MINERAL RESEARCH

High-Resolution Peripheral Quantitative Computed Tomographic Imaging of Cortical and Trabecular Bone Microarchitecture in Patients with Type 2 Diabetes Mellitus

(2010) Andrew J. Burghardt et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effects of preexisting microdamage, collagen cross-links, degree of mineralization, age, and architecture on compressive mechanical properties of elderly human vertebral trabecular bone

(2010) Helene Follet et al.   JOURNAL OF ORTHOPAEDIC RESEARCH

Changes in the contents of enzymatic immature, mature, and non-enzymatic senescent cross-links of collagen after once-weekly treatment with human parathyroid hormone (1–34) for 18 months contribute to improvement of bone strength in ovariectomized monkeys

(2010) M. Saito et al.   OSTEOPOROSIS INTERNATIONAL

Low Serum Level of the Endogenous Secretory Receptor for Advanced Glycation End Products (esRAGE) Is a Risk Factor for Prevalent Vertebral Fractures Independent of Bone Mineral Density in Patients With Type 2 Diabetes

(2009) M. Yamamoto et al.   DIABETES CARE

Pentosidine and Increased Fracture Risk in Older Adults with Type 2 Diabetes

(2009) Ann V. Schwartz et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Raloxifene ameliorates detrimental enzymatic and nonenzymatic collagen cross-links and bone strength in rabbits with hyperhomocysteinemia

(2009) M. Saito et al.   OSTEOPOROSIS INTERNATIONAL

Diabetic Patients Have an Increased Risk of Vertebral Fractures Independent of BMD or Diabetic Complications

(2008) Masahiro Yamamoto et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The Role of Advanced Glycation End Products in Progression and Complications of Diabetes

(2008) Su-Yen Goh et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs

(2008) M. Saito et al.   OSTEOPOROSIS INTERNATIONAL

Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate

(2008) S. Y. Tang et al.   OSTEOPOROSIS INTERNATIONAL

Serum Pentosidine Levels Are Positively Associated with the Presence of Vertebral Fractures in Postmenopausal Women with Type 2 Diabetes

(2007) Masahiro Yamamoto et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM